Chapel Hill-based University of North Carolina Health plans to add eight to 10 medical office buildings on its Eastowne campus, which opened in March 2021, according to a Jan. 30 report from chapelboro.com.
Category: ROOT
Remote cardiology monitor Implicity expands international presence
Cambridge, Mass.-based Implicity, a medtech company providing remote care solutions for cardiac patients, plans to expand internationally through a new partnership with the German Society for Cardiologists in Private Practice.
CMS updates Medicare cost report for hospitals
CMS has made several changes to the Medicare cost report for hospitals that include uncompensated care, Medicare disproportionate share hospital, bad debt and graduate medical education, according to legal news website JDSupra.
Tower Health names new CFO, hires advisory firm
West Reading, Pa.-based Tower Health has named Mike Eesley as its new CFO, effective immediately. The healthcare system has also retained advisory firm Houlihan Lokey to “strengthen the system’s financial structure.”
Pharmaceutical company taps former FDA gastroenterology director
Pharmaceutical company Jaguar Health added Andrew Mulberg, MD, former deputy director of the division of gastroenterology and inborn errors products at the FDA, as a consultant.
'Difficult patient' flag leads to treatment disparities, researchers say
Behavioral flags in electronic health records are designed to to help prevent violence against clinicians, but the flags might also prevent some patients from receiving full care, according to a recent study.
Utah 1st state to ban gender-affirming care for trans youth
Utah Gov. Spencer Cox signed legislation Jan. 28 that prohibits transgender youth from receiving gender-affirming healthcare.
Peterson Health shows operating improvement at end of 2022
Kerrville, Texas-based Peterson Health showed some positive signs of operating revenue outpacing expenses at the end of 2022 even as its half-year operating performance was in negative territory.
Humira's $114B monopoly to fall in February: 4 notes
Humira, AbbVie’s anti-inflammatory drug that has dozens of patents and $114 billion in U.S. sales, has a tight grasp on its market. That’s soon to change, The New York Times reported Jan. 28.
9 diseases with pandemic potential: WHO
Behind the scenes at the World Health Organization, epidemiologists track a list of the most important infectious diseases to keep tabs on. The list is of utmost importance — particularly in an age where a global pandemic has already occurred. This is …
